1. Huybrechts KF, Hernández-
Díaz S, Patorno E, et al.
Antipsychotic use in pregnancy and the risk for congenital malformations. JAMA Psychiat. 2016;73(9):938-946.
2. Hahn-Holbrook J, Cornwell-Hinrichs T, Anaya I. Economic
and health predictors of National Postpartum Depression
Prevalence: a systematic review, meta-
analysis, and meta-
regression of 291 studies from 56 countries. Front Psych.
2018;8:248.
3. Motrico E, Bina R, Domínguez-Salas S, et al. Impact of the
Covid-19 pandemic on perinatal mental health (Riseup-PPD-
COVID-19): protocol for an international prospective cohort
study. BMC Public Health. 2021;21(1):368.
4. Zhang L, Brown SJ, Shan Y, et al. CYP2D6 genetic polymorphisms and risperidone pharmacokinetics: a systematic review
and meta-analysis. Pharmacotherapy. 2020;40(7):632-647.
5. Toh S, Li Q, Cheetham TC, et al. Prevalence and trends in the
use of antipsychotic medications during pregnancy in the U.S.,
2001–
2007: a population-
based study of 585,615 deliveries.
Arch Womens Ment Health. 2013;16(2):149-157.
6. Wlodarczyk BJ, Ogle K, Lin LY, Bialer M, Finnell RH.
Comparative teratogenicity analysis of valnoctamide, risperidone, and olanzapine in mice. Bipolar Disord. 2015;17(6):
615-625.
7. Betcher HK, Montiel C, Clark CT. Use of antipsychotic
drugs during pregnancy. Curr Treat Options Psychiatry.
2019;6(1):17-31.
8. Ennis ZN, Damkier P. Pregnancy exposure to olanzapine, quetiapine, risperidone, aripiprazole and risk of congenital malformations. A systematic review. Basic Clin Pharmacol Toxicol.
2015;116(4):315-320.
9. Mannens G, Huang ML, Meuldermans W, Hendrickx J,
Woestenborghs R, Heykants J. Absorption, metabolism, and
excretion of risperidone in humans. Drug Metab Dispos. 1993;
21(6):1134-1141.
10. Vermeir M, Naessens I, Remmerie B, et al. Absorption, metabolism, and excretion of paliperidone, a new monoaminergic
antagonist, in humans. Drug Metab Dispos. 2008;36(4):769-779.
11. Mannens G, Meuldermans W, Snoeck E, Heykants J. Plasma
protein binding of risperidone and its distribution in blood.
Psychopharmacology. 1994;114(4):566-572.
12. Syrejshchikova T, Smolina N, Kondratyuk V, Dobretsov G,
Uzbekov M. Influence of antipsychotic drug risperidone on
human serum albumin affinity to organic anions. Curr Drug
Discov Technol. 2018;15(3):263-269.
13. Westin AA, Brekke M, Molden E, Skogvoll E, Castberg I, Spigset
O. Treatment with antipsychotics in pregnancy: changes in
drug disposition. Clin Pharmacol Ther. 2018;103(3):477-484.
14. Abduljalil K, Furness P, Johnson TN, Rostami-Hodjegan A,
Soltani H. Anatomical, physiological and metabolic changes
629
with gestational age during normal pregnancy: a database for
parameters required in physiologically based pharmacokinetic
modelling. Clin Pharmacokinet. 2012;51(6):365-396.
15. Polasek TM, Rostami-Hodjegan A. Virtual twins: understanding the data required for model-informed precision dosing. Clin
Pharmacol Ther. 2020;107(4):742-745.
16. Zhang Y, Mehta N, Muhari-Stark E, Burckart GJ, Anker J,
Wang J. Pediatric renal ontogeny and applications in drug development. J Clin Pharmacol. 2019;59(S1):S9-S20. doi:10.1002/
jcph.1490
17. Wang J, Kumar SS, Sherwin CM, et al. Renal clearance in
newborns and infants: predictive performance of population-
based modeling for drug development. Clin Pharmacol Ther.
2019;105(6):1462-1470.
18. Mattman A, Eintracht S, Mock T, et al. Estimating pediatric
glomerular filtration rates in the era of chronic kidney disease
staging. J Am Soc Nephrol. 2006;17(2):487-496.
19. Johnson TN, Rostami-Hodjegan A, Tucker GT. Prediction of the
clearance of eleven drugs and associated variability in neonates,
infants and children. Clin Pharmacokinet. 2006;45(9):931-956.
20. Rhodin MM, Anderson BJ, Peters AM, et al. Human renal function maturation: a quantitative description using weight and
postmenstrual age. Pediatr Nephrol. 2009;24(1):67-76.
21. Schwartz GJ, Work DF. Measurement and estimation of
GFR in children and adolescents. Clin J Am Soc Nephrol.
2009;4(11):1832-1843.
22. Mian AN, Schwartz GJ. Measurement and estimation of glomerular filtration rate in children. Adv Chronic Kidney Dis.
2017;24(6):348-356.
23. Pottel H, Mottaghy FM, Zaman Z, Martens F. On the relationship between glomerular filtration rate and serum creatinine in
children. Pediatr Nephrol. 2010;25(5):927-934.
24. Salem F, Johnson TN, Hodgkinson ABJ, Ogungbenro K,
Rostami-Hodjegan A. Does “birth” as an event impact maturation trajectory of renal clearance via glomerular filtration?
Reexamining data in preterm and full-term neonates by avoiding the creatinine bias. J Clin Pharmacol. 2021;61(2):159-171.
25. Björk J, Bäck S-E, Sterner G, et al. Prediction of relative glomerular filtration rate in adults: new improved equations based
on Swedish Caucasians and standardized plasma-creatinine assays. Scand J Clin Lab Invest. 2007;67(7):678-695.
26. Counahan R, Chantler C, Ghazali S, Kirkwood B, Rose F,
Barratt TM. Estimation of glomerular filtration rate from
plasma creatinine concentration in children. Arch Dis Child.
1976;51(11):875-878.
27. WebPlotDigitizer –Copyright 2010–2021 Ankit Rohatgi. Cited
March 22, 2022. https://apps.automeris.io/wpd/
28. PubChem. Risperidone. Cited October 13, 2021. https://pubch
em.ncbi.nlm.nih.gov/compound/5073
29. PubChem. Paliperidone. Cited March 22, 2022. https://pubch
em.ncbi.nlm.nih.gov/compound/115237
30. Huang M-L, Peer AV, Woestenborghs R, et al. Pharmacokinetics
of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects. Clin Pharmacol Ther.
1993;54(3):257-268.
31. Novalbos J, López-
Rodríguez R, Román M, Gallego-
Sandín
S, Ochoa D, Abad-Santos F. Effects of CYP2D6 genotype on
the pharmacokinetics, pharmacodynamics, and safety of
risperidone in healthy volunteers. J Clin Psychopharmacol.
2010;30(5):504-511.
17528062, 2023, 4, Downloaded from https://ascpt.onlinelibrary.wiley.com/doi/10.1111/cts.13473 by Kobe University, Wiley Online Library on [19/04/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
PBPK MODEL OF ANTIPSYCHOTICS IN PREGNANCY
32. Cabaleiro T, Ochoa D, López-
Rodríguez R, et al. Effect of
polymorphisms on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers. Hum
Psychopharmacol. 2014;29(5):459-469.
33. Nakagami T, Yasuifurukori N, Saito M, Tateishi T, Kaneo S.
Effect of verapamil on pharmacokinetics and pharmacodynamics of risperidone: In vivo evidence of involvement of
P-glycoprotein in risperidone disposition. Clin Pharmacol Ther.
2005;78(1):43-51.
34. Belotto KCR, Raposo NRB, Ferreira AS, Gattaz WF. Relative
bioavailability of two oral formulations of risperidone 2 mg:
a single-dose, randomized-sequence, open-label, two-period
crossover comparison in healthy Brazilian volunteers. Clin
Ther. 2010;32(12):2106-2115.
35. Janssen Pharmaceutical K.K. Report on the Deliberation Results.
Janssen Pharmaceutical K.K; 2016.
36. Snoeck E, Van Peer A, Mannens G, et al. Influence of age, renal
and liver impairment on the pharmacokinetics of risperidone
in man. Psychopharmacology. 1995;122(3):223-229.
37. Cui C, Sia JEV, Tu S, et al. Development of a physiologically
based pharmacokinetic (PBPK) population model for Chinese
elderly subjects. Br J Clin Pharmacol. 2021;87(7):2711-2722.
38. Administration AGD of HTG. Prescribing medicines in pregnancy database. Therapeutic goods administration (TGA).
Australian government department of Health; 2021. Cited
February 13, 2022. https://www.tga.gov.au/prescribing-medic
ines-pregnancy-database
39. Vermeulen A, Piotrovsky V, Ludwig EA. Population pharmacokinetics of risperidone and 9-
Hydroxyrisperidone in patients with acute episodes associated with bipolar I disorder.
J Pharmacokinet Pharmacodyn. 2007;34(2):183-206.
40. Rowland Yeo K, Venkatakrishnan K. Physiologically-
based
pharmacokinetic models as enablers of precision dosing in
drug development: pivotal role of the human mass balance
study. Clin Pharmacol Ther. 2021;109(1):51-54.
41. Buchanan ML, Easterling TR, Carr DB, et al. Clonidine pharmacokinetics in pregnancy. Drug Metab Dispos. 2009;37(4):702-705.
MAHDY et al.
42. McConnell C, Thoene M, Van Ormer M, et al. Plasma concentrations and maternal-umbilical cord plasma ratios of the six
Most prevalent carotenoids across five groups of birth gestational age. Antioxidants. 2021;10(9):1409.
43. Newport DJ, Calamaras MR, DeVane CL, Donovan J. Atypical
antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. Am J Psychiatry.
2007;164(8):1214-1220.
44. Lancz K, Palkovičová L, Patayová H, et al. Ratio of cord to maternal serum PCB concentrations in relation to their congener-
specific physicochemical properties. Int J Hyg Environ Health.
2015;218(1):91-98.
45. Binns R, O'Halloran SJ, Teoh S, Doherty K, Joyce DA. Placental
transfer of paliperidone during treatment with a depot formulation. J Clin Psychopharmacol. 2017;37(4):474-475.
46. Llanos-Paez CC, Staatz C, Lawson R, Hennig S. Comparison of
methods to estimate glomerular filtration rate in paediatric oncology patients. J Paediatr Child Health. 2018;54(2):141-147.
SUPPORTING INFORMATION
Additional supporting information can be found online
in the Supporting Information section at the end of this
article.
How to cite this article: Mahdy WYB, Yamamoto
K, Ito T, et al. Physiologically-based
pharmacokinetic model to investigate the effect of
pregnancy on risperidone and paliperidone
pharmacokinetics: Application to a pregnant
woman and her neonate. Clin Transl Sci. 2023;16:
618-630. doi:10.1111/cts.13473
17528062, 2023, 4, Downloaded from https://ascpt.onlinelibrary.wiley.com/doi/10.1111/cts.13473 by Kobe University, Wiley Online Library on [19/04/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
630 ...
論文の公開元へ
